ArticleFrontiers in pharmacology2021

Pan-Cancer Analysis Reveals Alternative Splicing Characteristics Associated With Immune-Related Adverse Events Elicited by Checkpoint Immunotherapy.

Xiujing He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.